Connect with us

Headlines of The Day

Delhi HC seeks details on capacity to manufacture COVID-19 vaccines

A 2-judge bench of the High Court on Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture their respective Covishield and Covaxin vaccines.

The Delhi High Court Thursday directed Serum Institute of India and Bharat Biotech to disclose their capacities to manufacture Covaxin, Covishield vaccines.

The high court also asked the Centre to explain in affidavit the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or between 45 to 60 years with comorbidities can receive vaccination.

A bench of Justices Vipin Sanghi and Rekha Palli said the two institutes– Serum Institute of India and Bharat Biotech — have more capacity to provide the vaccines but it seems that they are not exploiting it fully.

“We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So there has to be that sense of responsibility and urgency,” the bench said. Hindustan Times

Copyright © 2024 Medical Buyer

error: Content is protected !!